In a perspective of personalized care for smoking cessation, a better clinical characterization
of smokers with schizophrenia (SZ) is needed. The objective of this study was to determine …

Tobacco dependence remains one of the major preventable causes of premature morbidity
and mortality worldwide. There are well over 8,000 compounds present in tobacco and …

More than 5 million deaths a year are attributable to tobacco smoking, making it the largest
single cause of preventable death worldwide. The primary addictive component in tobacco …

Impaired neuroplastic responses following noninvasive brain stimulation have been
reported repeatedly in schizophrenia patients. These findings have been associated with …

In previous work, the novel heat-transfer method (HTM) for the detection of small molecules
with Molecularly Imprinted Polymers (MIP)-type receptors was presented. In this study we …

The relationship between tobacco smoke and schizophrenia (SZ) is well established.
Smoking is hypothesized to alleviate symptoms and reduce the adverse effects of …

Schizophrenia patients are at high risk for cigarette smoking, but the neurobiological
mechanisms of this comorbid association are relatively unknown. Long-term nicotine intake …

Tobacco use is strongly associated with cardiovascular disease and the only avoidable risk
factor associated with development of aortic aneurysm. While smoking is the most common …

Objective While behavioral risk factors for depression have been assessed in select
samples, previous research is limited in addressing such correlates across the lifespan. To …

The discovery of microRNAs (miRNAs) a little over 20 years ago was revolutionary given
that miRNAs are essential to numerous physiological and physiopathological processes …